Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T35463 |
(±)14(15)-EET
(±)14,15-EET,(±)14,15-EpETrE,(±)14(15)-EET |
||
(±)14(15)-EET is a metabolite of arachidonic acid that is formed via epoxidation of arachidonic acid by cytochrome P450.[1],[2] It prevents increases in leukotriene B4, ICAM-1, and chemokine (C-C motif) ligand 1 (CCL2) induced by oxidized LDL in primary rat pulmonary artery endothelial cells (RPAECs) when used at a concentration of 1 μM.[3] (±)14(15)-EET induces dilation of preconstricted isolated canine coronary arterioles (EC50 = 0.2 pM).[4] It reduces myocardial infarct size as a percentage o... | |||
T35494 | (±)11(12)-EET | ||
(±)11(12)-EET is a fully racemic version of the R/S enantiomeric forms biosynthesized from arachidonic acid by cytochrome P450 enzymes.[1][2][3[]A higher proportion of 11(R),12(S)-EET is produced by the CYP450 isoforms CYP2C23 and CYP2C24 while CYP2B2 produces a higher proportion of 11(S),12(R)-EET.[3]11(12)-EET has been shown, along with 8(9)-EET to play a role in the recovery of depleted calcium pools in cultured smooth muscle cells[4] It also inhibits basolateral 18-pS potassium channels in t... | |||
T36070 |
(±)5(6)-EET
|
||
5(6)-EET is a fully racemic version of the enantiomeric forms biosynthesized from arachidonic acid by cytochrome P450 enzymes. In solution, 5(6)-EET degrades into 5,6-DiHET and 5(6)-δ-lactone, which can be converted to 5(6)-DiHET and quantified by GC-MS. In neuroendocrine cells, such as the anterior pituitary and pancreatic islets, 5(6)-EET has been implicated in the mobilization of calcium and hormone secretion. 5(6)-EET is an inhibitor of T-type voltage-gated calcium channels (Cav3) that inhib... | |||
T35464 |
(±)14(15)-EET-SI
|
||
Arachidonic acid is metabolized in the vascular endothelium to epoxytrienoic acids (EETs or EpETrEs) by cytochrome P450 enzymes. The EETs are released in response to acetylcholine, bradykinin, arachidonic acid, or cyclic stretch. (±)14(15)-EET-SI is the methyl sulfonamide analog of 14(15)-EET. This substitution results in a metabolically more stable compound because it is not sensitive to β-oxidation or membrane esterification. (±)14(15)-EET-SI is equipotent to 14(15)-EET in vascular agonist act... | |||
T36152 |
14S(15R)-EET
|
||
14S(15R)-EET is an oxylipin and a cytochrome P450 metabolite of arachidonic acid .114S(15R)-EET binds to isolated guinea pig monocytes with a Kivalue of 612.5 nM in a competitive binding assay using [3H]14(15)-EET.2It induces dilation of precontracted isolated canine epicardial arterioles (EC50= 4 pM) and denuded porcine subepicardial arterioles (EC50= 3 pM).3Unlike 14R(15S)-EET, 14S(15R)-EET does not inhibit COX in enzyme assays or isolated platelets.4 1.Daikh, B.E., Lasker, J.M., Raucy, J.L., ... | |||
T83451 |
14,15-Epoxyeicosatrienoic acid
14,15-EET |
||
14,15-Epoxyeicosatrienoic acid(14,15-EET)是花生四烯酸的代谢物,具有显著的体内抑制血小板聚集的作用。此外,它能促进星形胶质细胞清除Aβ,因而在老年痴呆症的研究中具有潜在应用价值。 | |||
T83869 |
(±)16,17-EDT
(±)16,17-Epoxydocosatrienoic Acid,(±)-Dihomo-16,17-EET,(±)16,17-EpDoTrE |
||
(±)16,17-EDT,一种经由细胞色素P450 (CYP) 途径形成的腺苷酸代谢物和氧脂肪酸,能够诱导分离的猪小动脉舒张(EC50 = 11 pM)。此外,(±)16,17-EDT 亦能促进以TP受体激动剂U-46619 预收缩的分离牛冠状动脉的松弛。 | |||
T83868 |
(±)13,14-EDT
(±)13,14-Epoxydocosatrienoic Acid,(±)13,14-EpDoTrE,(±)-Dihomo-13,14-EET |
||
(±)13,14-EDT是一种氧脂和腎上腺酸的代谢产物,通过细胞色素P450(CYP)途径形成。在50 nM的浓度下,它能激活分离的大鼠冠状小动脉平滑肌细胞中的大导电钙激活钾通道(KCa1.1/BK),并导致分离的猪小动脉扩张(EC50 = 12 pM)。(±)13,14-EDT还能使用TP受体激动剂U-46619预收缩的分离牛冠状动脉放松。 | |||
T8315 |
1-Cyclohexyl-3-dodecyl urea
CDU,N-Cyclohexyl-N-dodecyl urea,NCND |
Epoxide Hydrolase | Metabolism |
1-Cyclohexyl-3-dodecyl urea (NCND) 是高选择性的可溶性环氧化物水解酶 (sEH) 抑制剂,能够增强血管紧张素 II (Ang II) 高血压中的环氧二十碳三烯酸 (EETs) 水平,并降低血压。 | |||
T21609L |
Beta-Sheet Breaker Peptide iAβ5 Acetate
Beta-Sheet Breaker Peptide iAβ5 Acetate(182912-74-9 Free base) |
Others | Others |
Beta-Sheet Breaker Peptide iAβ5 Acetate 抑制大鼠脑模型中的淀粉样蛋白生成。 | |||
T38723 |
β-Aminoarteether
β-Aminoarteether,SM934 free base |
Others | Others |
β-Aminoarteether (SM934 free base) 是一种具有口服活性的青蒿素衍生物。β-Aminoarteether 可用于炎症和自身免疫疾病研究,如狼疮疾病。 | |||
T124089 | Preethuliacoumarin | ||
Preethuliacoumarin 是一种有用的有机化合物,可用于生命科学领域的相关研究。其产品编号为 T124089,CAS号为 85431-45-4。 | |||
T31361 |
Deethyl-LSD
LAE 32,Lysergic acid ethylamide,LAE-32,N-Ethyllysergamide,LAE32 |
||
Deethyl-LSD is reported to have some LSD-like effects but is weaker and shorter-lasting, with an active dose reported to be between 0.5 and 1.5 milligrams. | |||
T30357 | Benzeneethanol, 3-(1-methylethyl)- | ||
Benzeneethanol, 3-(1-methylethyl)- is a bioactive chemical. | |||
T40833 | ω-Hydroxy-DEET | ||
ω-Hydroxy-DEET, a significant metabolite of the insect repellent N-N-diethyl-meta-toluamide (DEET), exhibits anti-proliferative properties. DEET, renowned for being a spatial repellent and irritant, is frequently employed to deter mosquito contact. | |||
T29312 | 1-Piperidineethanol, alpha-(5-(3-hydroxyphenyl)-3-isoxazolyl)- | ||
1-Piperidineethanol, alpha-(5-(3-hydroxyphenyl)-3-isoxazolyl)- is a bioactive chemical. | |||
T125668 |
Benzeneethanol, 4-octyl-, 1-acetate
|
||
Benzeneethanol, 4-octyl-, 1-acetate 是一种有用的有机化合物,可用于生命科学领域的相关研究,其产品编号为 T125668。 | |||
T35731 |
Deethylindanomycin
|
||
Deethylindanomycin is a polyether antibiotic that has been found in S. setonii. It is active against a variety of Gram-positive bacteria, including various strains of S. aureus and Streptococcus, as well as one strain of S. pneumoniae (MICs = 4, 4, and 2 μg/ml, respectively). It is also active against coccidia in vitro, inhibiting E. tenella development, but is inactive against E. tenella infection in chicks when administered at a dose of 200 μg/g in the diet. Deethylindanomycin acts as an ionop... | |||
T124533 | N-Methylcyclohexaneethaneamine | ||
N-Methylcyclohexaneethaneamine 是一种有用的有机化合物,可用于生命科学领域的相关研究。其产品编号为 T124533,CAS号为 62141-38-2。 | |||
T65359 |
N-FormylglycineEthylEster
|
||
N-FormylglycineEthylEster 是一种有用的有机化合物,可用于生命科学领域的相关研究。其产品编号为 T65359,CAS号为 3154-51-6。 | |||
T125667 |
Benzeneethanol, 4-octyl
|
||
Benzeneethanol, 4-octyl 是一种有用的有机化合物,可用于生命科学领域的相关研究。其产品编号为 T125667,CAS号为 162358-05-6。 | |||
T36151 |
14,15-EE-8(Z)-E
|
||
Epoxyeicosatrienoic acids (EETs), such as 11(12)-EET and 14(15)-EET, are cytochrome P450 metabolites of arachidonic acid that have been identified as endothelium-derived hyperpolarizing factors with vasodilator activity. 14,15-EE-8(Z)-E is a structural analog of 14(15)-EET that demonstrates potent vasodilator agonist activity in bovine coronary arteries similar to that of 14(15)-EET. | |||
T36150 |
14,15-EE-5(Z)-E
|
||
Epoxyeicosatrienoic acids (EETs), such as 11(12)-EET and 14(15)-EET, are cytochrome P450 metabolites of arachidonic acid that have been identified as endothelium-derived hyperpolarizing factors with vasodilator activity. 14,15-EE-5(Z)-E is a structural analog of 14,15-epoxyeicosatrienoic acids (14,15-EET) that antagonizes EET-induced relaxation of vascular smooth muscle. Relaxation of U46619-constricted bovine arteries by 14,15-EET could be inhibited approximately 80% by 14,15-EE-5(Z)-E at a con... | |||
T36556 |
(±)5(6)-DiHET lactone
|
||
5,6-DiHET lactone is a lactonized form of 5,6-EET and 5,6-DiHET. In solution, 5(6)-EET degrades into 5(6)-DiHET and 5(6)-δ-lactone, which can be converted to 5(6)-DiHET and quantified by GC-MS. 5,6-DiHET potently induces vasodilation of isolated canine coronary arterioles, with 41 and 100% inhibition occurring at 0.01 and 100 pM, respectively. It also induces vasodilation in isolated human microvessels and increases intracellular calcium levels in a dose-dependent manner, an effect that can be b... | |||
T37227 |
(±)8(9)-DiHET
|
||
Epoxide hydrolases convert the EETs into vicinal diols, with the concurrent loss of much of their biological activity. The 8(S),9(R)-EET isomer is metabolized by platelet COX to form 8(S),9(R),11(R)-THETA, a trihydroxy fatty acid which may act as a renal vasoconstrictor. | |||
T36462 |
CAY10770
CAY10770 |
||
CAY10770 is an inhibitor of the cytochrome P450 (CYP) isoform CYP4Z1 (IC50= 5.9 μM).1It is selective for CYP4Z1 over CYP4A11, CYP4F2, CYP4F3a, CYP4F3b (IC50s = 187-282 μM) but does inhibit CYP4F8 and CYP4F12 (IC50s = 167 and 91 μM, respectively). CAY10770 (3 μM) inhibits the production of 14(15)-EET, 19-HETE, and 14(15)-DiHET by 83, 86, and 80%, respectively, in T47D breast cancer cells expressing CYP4Z1. 1.Kowalski, J.P., McDonald, M.G., Pelletier, R.D., et al.Design and characterization of the... | |||
T35712 |
Debutyldronedarone hydrochloride
SR35021 hydrochloride |
||
N-Desbutyl dronedarone is an active metabolite of the antiarrhythmic agent dronedarone .1,2,3It is formed from dronedarone by cytochrome P450s (CYPs) and monoamine oxidase (MAO) in human hepatocyte preparations.4N-Desbutyl dronedarone inhibits the binding of 3,3’,5-triiodo-L-thyronine to the thyroid hormone receptors TRα1and TRβ1(IC50s = 59 and 280 μM for the chicken and human receptors, respectively).1It inhibits CYP2J2-mediated formation of 14,15-EET from arachidonic acid and soluble epoxide h... | |||
T37235 |
(±)16(17)-EpDPA
(±)16,17-EpDPE,(±)16,17 EDP,(±)16,17-epoxy Docosapentaenoic Acid,(±)16,17-epoxy DPA,(±)16(17)-EpDPA |
||
EDHF (endothelium-derived hyperpolarizing factor) is an unidentified mediator released from vascular endothelial cells in response to acetylcholine and bradykinin which is distinct from the NOS- (nitric oxide) and COX-derived (prostacyclin) vasodilators.[1],[2]Cytochrome P450 (CYP450) metabolism of polyunsaturated fatty acids produces epoxides such as (±)14(15)-EET which are prime candidates for the actual active mediator.[3] However, the CYP450 metabolites of eicosapentaenoic acid and docosahex... | |||
T37333 | (±)11(12)-DiHET MaxSpec® Standard | ||
(±)-11(12)-DiHET is an oxylipin. 11(S),12(S)-DiHET and 11(R),12(R)-DiHET are vicinal diols formedviaenzymatic hydration of 11(12)-EET by cytosolic or soluble epoxide hydrolases in a non-stereoselective manner.1,2,3(±)11(12)-DiHET MaxSpec standard is a quantitative grade standard of (±)11(12)-DiHET that has been prepared specifically for mass spectrometry and related applications where quantitative reproducibility is required. The solution has been prepared gravimetrically and is supplied in a de... |